{"slug":"pt-141-gut","verification":{"valid":true,"entries":2,"head":"713515c37a40d09f0fea1d8fa537a2e2f15a9fe87937c10f4a870184d376d75d"},"energy":{"passes":2,"tokens_in":14847,"tokens_out":2764,"tokens_total":17611,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"713515c37a40d09f0fea1d8fa537a2e2f15a9fe87937c10f4a870184d376d75d"},"provenance":[{"ts":"2026-06-30T01:16:04.899Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Gut\nSlug: pt-141-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / ","response":"{\n  \"slug\": \"pt-141-gut\",\n  \"title\": \"PT-141 for Gut: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nGut issues often involve layers of degeneration where repair pathways lag behind ongoing stress or inflammation. The melanocortin system, which PT-141 targets in the central nervous system, has some presence in broader physiology, but direct links to intestinal tissue repair remain unexplored in available data. If your gut symptoms tie into central arousal or motivation pathways, or if side effects like nausea appear, that context matters. PT-141 is not positioned as a gut-specific compound.\\n\\n## Why PT-141 might help you\\n\\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts centrally on melanocortin receptors, primarily MC4R in the hypothalamus. This pathway influences arousal and motivation. For someone whose gut complaints overlap with disrupted CNS signaling (such as stress-related motility changes), the discussion centers on whether central activation could indirectly support gut-brain communication. No direct tissue repair data exists for intestinal lining or microbiome balance. If your gut problem stems from mechanical or inflammatory breakdown rather than CNS arousal, this mechanism does not address those layers. Side effect reports note slowed gastric emptying and nausea, which could add mechanical load or discomfort rather than relieve it.\\n\\n## How these fit together\\n\\nSingle-compound focus. PT-141 maps to the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile. Here the focus stays on one compound and one primary layer.\\n\\n## What the evidence actually shows\\n\\nHuman trials of bremelanotide focus on hypoactive sexual desire disorder. Two phase 3 studies measured desire scores and distress but did not assess gastrointestinal endpoints ","tokens_in":14847,"tokens_out":2764,"cost":0,"prev":"genesis","hash":"ddfeed84cf26392d5264c784e9a7f8592b98d0bcba66adc78c0e2d51afa9d7a1"},{"ts":"2026-07-17T02:41:06.553Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-gut","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ddfeed84cf26392d5264c784e9a7f8592b98d0bcba66adc78c0e2d51afa9d7a1","hash":"713515c37a40d09f0fea1d8fa537a2e2f15a9fe87937c10f4a870184d376d75d"}]}